Effects of combined therapy of Phosphatidylinositol 3p-Kinase and Paclitaxel in human lung cancer nude mice model

Effects of combined therapy of Phosphatidylinositol 3p-Kinase and Paclitaxel in human lung cancer nude mice model

Background and objective Increasing evidence suggests that aberrant activation of PI3K/Akt is involved in many human cancers, and that inhibition of the PI3K/Akt pathway might be a promising strategy for cancer therapy. The aims of this study is to evaluate the effects of combined therapy of Phospha...

Full description

Bibliographic Details
Main Authors: Yajuan REN, Lizhi ZHANG, Li YANG, Jianxin PANG, Dongge LIU, Dongsheng XIONG, Chunzheng YANG, Lan LAN, Tieying SUN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Phosphatidylinositol 3-Kinase inhibitor
LY294002
Paclitaxel
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.02.029&path%5B%5D=44

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.02.029&path%5B%5D=44

Similar Items